Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 19/20 | 0.61 |
| ▸ | FNTB | P49356 | 19/20 | 0.61 |
| ▸ | PGGT1B | P53609 | 18/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.53 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.49 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8425942 | 1.00 | FNTA (0.61) | FNTAFNTBPGGT1BKCNH2CYP11B1 | |
| SCHEMBL8088609 | 1.00 | FNTA (0.61) | FNTAFNTBPGGT1BKCNH2CYP11B1 | |
| SCHEMBL8097383 | 0.95 | FNTA (0.58) | FNTAFNTBPGGT1BKCNH2CYP11B1 | |
| SCHEMBL8531147 | 0.95 | FNTA (0.58) | FNTAFNTBPGGT1BKCNH2CYP11B1 | |
| SCHEMBL8095394 | 0.94 | FNTA (0.60) | FNTAFNTBPGGT1BKCNH2CYP11B1 | |
| SCHEMBL8099959 | 0.90 | FNTA (0.50) | FNTAFNTBPGGT1BKCNH2CYP11B1 | |
| SCHEMBL8102502 | 0.89 | FNTA (0.49) | FNTAFNTBPGGT1BKCNH2CYP11B1 | |
| SCHEMBL8441885 | 0.89 | FNTA (0.49) | FNTAFNTBPGGT1BKCNH2CYP11B1 | |
| SCHEMBL446562 | 0.89 | FNTA (0.54) | FNTAFNTBPGGT1BKCNH2CYP11B1 | |
| SCHEMBL8089026 | 0.89 | FNTA (0.51) | FNTAFNTBPGGT1BKCNH2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6127366-A | ANTICARCINOGENIC OR ANTITUMOR AGENTS | MERCK & CO., INC. (US) | 2000-10-03 | — | — | US | disclosed |